BOSTON – Y. Jenny Chen, PhD has joined Mintz as a Member in the firm’s highly-regarded Intellectual Property (IP) practice, adding further expertise and depth to the firm’s life sciences offering.

“Jenny is a highly regarded life sciences patent attorney and IP strategist.  She has depth of experience in the areas of antibodies, cell therapies, and gene editing that will enhance our capabilities servicing clients in the life sciences sector,” said Managing Member, Bob Bodian.

“Our cross-border IP life sciences practice is in growth mode, and Jenny’s addition represents an added layer of expertise. She counsels US-based and international clients in a range of patent-related matters and we are excited welcome her to the team,” said Intellectual Property Chair Michael Renaud.

Jenny’s practice encompasses US and international patent prosecution, IP due diligence for transactions, clearance analyses, licensing, opinion work, and post-grant proceedings. She has extensive experience with providing strategic counseling on the life-cycle management of both biological and small molecule products.

Prior to joining Mintz, Jenny practiced patent law for more than 15 years, most recently as a partner at an international law firm.

Jenny is the fourth Member to join Mintz’s leading IP practice in the last six months. San Diego-based Reza Dokhanchy joined the firm in May, meanwhile in late September, the firm added IP litigator, Vanessa Yen in New York, and in early October, IP attorney Anthony de Fazekas joined Mintz’s Toronto office.

Mintz creates breakthrough legal strategies that help clients solve problems and forge ahead. Our attorneys combine legal, business, and industry insight to help navigate shifting challenges. We help clients comply with evolving regulations and compete in emerging markets. The firm has incredible depth of experience in the sectors driving innovation and growth including life sciences, private equity, energy & sustainability, and technology. Mintz is recognized as a litigation powerhouse.